Friday 6 November 2026
Export CLPT’s income statement to Excel — free account
ClearPoint Neuro, Inc.
CLPT Healthcare Medical Devices
ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024.
- Revenue
- +36.3%
- EPS
- −14.7%
- Free cash flow
- −58.1%
- Total debt
- +74.1%
Quarter to September 2026, against a year earlier
8.60
0.09
−1.04%
Follow CLPT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (167.52%) | (226.52%) | (149.72%) | (95.64%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 2 | 4 | 4 | |
| (41.75%) | (46.21%) | (47.08%) | (37.30%) | ||
ROIC |
(62.84%) | (61.31%) | (50.31%) | (48.45%) | |
Return on Tangible Assets |
(60.26%) | (83.08%) | (60.16%) | (46.05%) | |
Average Days of Receivables |
64.32 | 72.48 | 77.85 | 64.66 | |
Free Cash Flow per Share |
(1.07) | (1.04) | (0.90) | (0.86) | |
Free Cash Flow |
(33.22) | (31.29) | (26.70) | (24.45) | |
Capital Expenditures |
(1.04) | (1.11) | (0.98) | (0.52) | |
| Other line items | |||||
Cash ROIC |
(26.73%) | (34.62%) | (25.66%) | (19.87%) | |
Accounts Receivable Turnover |
7.57 | 6.68 | 6.60 | 6.57 | |
Accounts Payable Turnover |
19.70 | 8.58 | 8.63 | 11.00 | |
Inventory Turnover |
2.15 | 2.09 | 2.02 | 1.88 | |
Average Days of Payables |
22.03 | 49.71 | 55.59 | 32.11 | |
Days of Inventory on Hand |
203.07 | 203.48 | 204.55 | 213.67 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
36.07% | 37.47% | 37.03% | 37.59% | |
Selling, General and Administrative Expense of Revenue |
95.88% | 98.56% | 90.50% | 89.15% | |
Share Based Compensation of Revenue |
18.35% | 20.09% | 20.90% | 22.13% | |
Interest Coverage |
(6.03) | (6.44) | (7.02) | (9.71) | |
Operating CF/Net income |
0.89 | 0.87 | 0.88 | 0.94 | |
Depreciation/Fixed assets |
1.65 | 1.31 | 1.08 | 0.89 | |
Capex/Depreciation |
(0.20) | (0.28) | (0.31) | (0.22) | |
Revenue per Share |
1.47 | 1.40 | 1.37 | 1.31 | |
Operating CF per Share |
(1.04) | (1.00) | (0.87) | (0.84) | |
Capex per Share |
(0.03) | (0.04) | (0.03) | (0.02) | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026